I think Dew predicted that ENTA would be a bargain at that $17-19 price, since he thought they would be very likely to get superb Phase 3 results given their Phase 2 results. I seem to remember him saying that HCV the data is reproducible. I could be misremembering.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.